Kaya Holdings (KAYS) Cash & Equivalents (2011 - 2025)
Kaya Holdings (KAYS) recorded quarterly Cash & Equivalents of $26087.0 in Q3 2025, down 45.82% quarter-over-quarter from $48146.0 in Q2 2025, and down 59.74% on a YoY basis from $64794.0 in Q3 2024.
Kaya Holdings (KAYS) Cash & Equivalents (2011 - 2025) Analysis & Trends
Kaya Holdings' Cash & Equivalents history runs 15 years deep, the most recent figure standing at $26087.0 for Q3 2025.
- In Q3 2025, Cash & Equivalents fell 59.74% year-over-year to $26087.0; the TTM figure through Sep 2025 stood at $26087.0 (down 59.74% YoY), while the FY2024 annual figure was $39668.0, up 36.28% from the prior year.
- Cash & Equivalents was $26087.0 for Q3 2025 at Kaya Holdings, down from $48146.0 in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $565979.0 in Q4 2021 to a low of $18330.0 in Q4 2022.
- Historically, Cash & Equivalents has averaged $88512.2 across 5 years, with a median of $56266.0 in 2021.
- The sharpest annual moves came in 2021 and 2022: Cash & Equivalents surged 1211.29% in 2021, then sank 96.76% in 2022.
- A 5-year view of Cash & Equivalents shows it stood at $565979.0 in 2021, then tumbled by 96.76% to $18330.0 in 2022, then soared by 58.8% to $29108.0 in 2023, then soared by 36.28% to $39668.0 in 2024, then slumped by 34.24% to $26087.0 in 2025.
- The last three Cash & Equivalents figures came in at $26087.0 (Q3 2025), $48146.0 (Q2 2025), and $50718.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 3.74 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 1.94 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 1.28 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 40.42 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 266.50 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 428.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 351.55 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 222.27 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 498.58 Mn |
| 10 | Kaya Holdings | - | - | 5,370.00 | 26,087.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 26,087.00 |
| Jun 30, 2025 | 48,146.00 |
| Mar 31, 2025 | 50,718.00 |
| Dec 31, 2024 | 39,668.00 |
| Sep 30, 2024 | 64,794.00 |
| Jun 30, 2024 | 61,282.00 |
| Mar 31, 2024 | 74,997.00 |
| Dec 31, 2023 | 29,108.00 |
| Sep 30, 2023 | 60,268.00 |
| Jun 30, 2023 | 125,887.00 |
| Mar 31, 2023 | 30,489.00 |
| Dec 31, 2022 | 18,330.00 |
| Sep 30, 2022 | 40,408.00 |
| Jun 30, 2022 | 46,605.00 |
| Mar 31, 2022 | 202,639.00 |
| Dec 31, 2021 | 565,979.00 |
| Sep 30, 2021 | 56,266.00 |
| Jun 30, 2021 | 69,274.00 |
| Mar 31, 2021 | 70,786.00 |
| Dec 31, 2020 | 43,162.00 |